Abstract
The organ that is affected first and most severely in intraabdominal sepsis is the lung. Oxygen radicals and active neutrophils in the lung are important sources for severe pulmonary inflammation leading to acute lung injury (ALI)/acute respiratory distress syndrome. The aim of this study was to investigate the effects of leflunomide, an immunomodulatory agent, on oxidant/antioxidant status with nitric oxide (NO) level and myeloperoxidase (MPO) activity in rats with sepsis-induced ALI. Fifty male Wistar albino rats were divided into five groups: control, sham, sepsis, leflunomide (10 mg/kg, intragastrically for two doses with an 8 h interval prior to the experiment) and sepsis + leflunomide. After the animals were anesthetized with ketamine and xylazine, the abdominal cavity was opened and ligated just below the ileocaecal valve with 3–0 silk. The antimesentric surface of the cecum was perforated and the cecum was gently compressed until fecal matter was extruded to induce sepsis. None of the rats received antibiotics during the experimental procedures. The experiment was ended 24 h after cecal ligation puncture (CLP) with the cervical dislocation under anesthesia. The lung tissues were removed for analysis of biochemical parameters and light microscopic investigation. The lung superoxide dismutase (SOD), catalase and glutathione peroxidase activities were decreased in the sepsis group as compared to the group control, sham, leflunomide and sepsis + leflunomide (P < 0.05), and SOD activity were significantly higher in group sepsis + leflunomide than sham, control, leflunomide and sepsis group (P < 0.05). The lung MPO, malondialdehyde (MDA), protein carbonyl and NO levels were higher in the sepsis group when compared to group control, sham, leflunomide and sepsis + leflunomide (P < 0.05), and MPO, MDA and NO levels were higher in the sepsis + leflunomide group than in the sham, control and leflunomide group (P < 0.05). The light microscopic evaluation showed that pulmonary architecture was preserved, and infiltration of neutrophil and edema decreased in sepsis + leflunomide group. The grade of alveolar damage was significantly decreased in sepsis + leflunomide group in comparison with sepsis group (P < 0.05). Our findings suggested that leflunomide attenuated the lung injury after CLP-induced sepsis by inhibition of neutrophils accumulation and increasing endogenous antioxidant capacity.
Similar content being viewed by others
References
Chow CW, Herrera Abreu MT, Suzuki T, Downey GP (2003) Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol 29:427–431. doi:10.1165/rcmb.F278
Lang JD, McArdle PJ, O’Reilly PJ, Matalon S (2002) Oxidant–antioxidant balance in acute lung injury. Chest 122:314–320. doi:10.1378/chest.122.6_suppl.314S
Thompson BT (2003) Glucocorticoids and acute lung injury. Crit Care Med 31:253–257. doi:10.1097/01.CCM.0000057900.19201.55
Manocha S, Feinstein D, Kumar A, Kumar A (2002) Novel therapies for sepsis: antiendotoxin therapies. Expert Opin Investig Drugs 11:1795–1812. doi:10.1517/13543784.11.12.1795
Leeper-Woodford SK, Carey PD, Byrne K, Jenkins JK, Fisher BJ, Blocher C et al (1991) Tumor necrosis factor. Alpha and beta subtypes appear in circulation during onset of sepsis-induced lung injury. Am Rev Respir Dis 143:1076–1082
Brower RG, Ware LB, Berthiaume Y, Matthay MA (2001) Treatment of ARDS. Chest 120:1347–1367. doi:10.1378/chest.120.4.1347
Silverman E, Spiegel L, Hawkins D, Petty R, Goldsmith D, Schanberg L et al (2005) Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 52:554–562. doi:10.1002/art.20861
Kalgutkar AS, Nguyen HT, Vaz AD, Doan A, Dalvie DK, McLeod DG et al (2003) In vitro metabolism studies on the isoxazole ring scission in the anti-inflammatory agent lefluonomide to its active alpha-cyanoenol metabolite A771726: mechanistic similarities with the cytochrome P450-catalyzed dehydration of aldoximes. Drug Metab Dispos 31:1240–1250. doi:10.1124/dmd.31.10.1240
Zhang L, Qi Z, Wu D, Shan S, Ekberg H (2004) Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection. Scand J Immunol 59:255–260. doi:10.1111/j.0300-9475.2004.01401.x
Yao HW, Li J, Chen JQ, Xu SY (2004) Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats. Acta Pharmacol Sin 25(7):915–20
Chong AS, Huang W, Liu W, Luo J, Shen J, Xu W et al (1999) In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression. Transplantation 68:100–109. doi:10.1097/00007890-199907150-00020
Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock—a review of laboratory models and proposal. J Surg Res 29:189–201. doi:10.1016/0022-4804(80)90037-2
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reaction. J Biol Chem 193:265–271
Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500
Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126. doi:10.1016/S0076-6879(84)05016-3
Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–170
Wei H, Frenkel K (1993) Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis 14:1195–1201. doi:10.1093/carcin/14.6.1195
Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407–421
Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440–1443
Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG et al (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478
Sener G, Toklu H, Ercan F, Erkanli G (2005) Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis. Int Immunopharmacol 5:1387–1396. doi:10.1016/j.intimp.2005.03.007
Babayigit H, Kucuk C, Sozuer E, Yazici C, Kose K, Akgun H (2005) Protective effect of beta-glucan on lung injury after cecal ligation and puncture in rats. Intensive Care Med 31:865–870. doi:10.1007/s00134-005-2629-x
Guo RF, Ward PA (2007) Role of oxidants in lung injury during sepsis. Antioxid Redox Signal 9:1991–2002. doi:10.1089/ars.2007.1785
Reutershan J, Ley K (2004) Bench-to-bedside review: acute respiratory distress syndrome—how neutrophils migrate into the lung. Crit Care 8:453–461. doi:10.1186/cc2881
Victor VM, Rocha M, Esplugues JV, De la Fuente M (2005) Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 11:3141–3158. doi:10.2174/1381612054864894
Ritter C, Andrades M, Frota Júnior ML, Bonatto F, Pinho RA, Polydoro M et al (2003) Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med 29:1782–1789. doi:10.1007/s00134-003-1789-9
Demirbilek S, Ersoy MO, Demirbilek S, Karaman A, Akin M, Bayraktar M et al (2004) Effects of polyenylphosphatidylcholine on cytokines, nitrite/nitrate levels, antioxidant activity and lipid peroxidation in rats with sepsis. Intensive Care Med 30:1974–1978. doi:10.1007/s00134-004-2234-4
Karaman A, Fadillioglu E, Turkmen E, Tas E, Yilmaz Z (2006) Protective effects of leflunomide against ischemia-reperfusion injury of the rat liver. Pediatr Surg Int 22:428–434. doi:10.1007/s00383-006-1668-x
Karaman A, Iraz M, Kirimlioglu H, Karadag N, Tas E, Fadillioglu E (2006) Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment. Pediatr Surg Int 22:701–708. doi:10.1007/s00383-006-1744-2
Reddy SV, Wanchu A, Khullar M, Govindrajan S, Bambery P (2005) Leflunomide reduces nitric oxide production in patients with active rheumatoid arthritis. Int Immunopharmacol 5:1085–1090. doi:10.1016/j.intimp.2004.11.013
Manna SK, Aggarwal BB (1999) Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression. J Immunol 162:2095–2102
Li WD, Ran GX, Teng HL, Lin ZB (2002) Dynamic effects of leflunomide on IL-1, IL-6, and TNF-alpha activity produced from peritoneal macrophages in adjuvant arthritis rats. Acta Pharmacol Sin 23:752–756
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ozturk, E., Demirbilek, S., Begec, Z. et al. Does leflunomide attenuate the sepsis-induced acute lung injury?. Pediatr Surg Int 24, 899–905 (2008). https://doi.org/10.1007/s00383-008-2184-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-008-2184-y